Bausch Health Companies Inc

BHC

$28.72

+62.7% (1 year change)

Market Cap

$10.2 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$16.08 - $34.80

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

-7.96x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $10.2 Billion
Enterprise Value $33 Billion
Dividend Yield $0.00 (0.0%)
1 Year Return +62.7%
52-Week High $34.80
52-Week Low $16.08
Beta 1.11
Outstanding Shares 358 Million
Avg 30 Day Volume 1.2 Million

Valuation

P/E Ratio -7.96
PEG -9.65
Earnings per Share -$3.61
Price to Sales Ratio 1.25
Price to Book Ratio -14.36
Revenue to Enterprise Value 3.9
EBIT to Enterprise Value 20.41
Total Debt to Enterprise Value 0.71
Debt to Equity -34.12

Profitability

Revenue $8.48 Billion
Gross Profit $6.06 Billion
EBIT $1.62 Billion
Net Income -$1.29 Billion
Profit Margin -15.18%
Quarterly Earnings Growth (YoY) +82.5%
Return on Equity 187.34%
Return on Assets -4.28%
Return on Invested Capital 6.6%

Insider trades

No purchases

No sells

No purchases

28,037 shares sold (2 transactions)

11,400 shares bought (2 transactions)

No sells

No purchases

No sells

Q1 2021 Q2 2021 Q3 2021 Q4 2021

About Bausch Health Companies Inc

Employees: 21,100

Industry: Pharmaceutical Preparation Manufacturing

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.

Similar stocks

Onconova Therapeutics Inc
Opko Health Inc

News

Dimensional Fund Advisors LP Has $31.50 Million Position in Bausch Health Companies Inc. (NYSE:BHC)

Dimensional Fund Advisors LP Has $31.50 Million Position in Bausch Health Companies Inc. (NYSE:BHC)

Dimensional Fund Advisors LP lowered its position in shares of Bausch Health Companies Inc. (NYSE:BHC) by 3.7% in the second quarter, according to the company in its most recent disclosure with the...

 Dakota Financial News Dakota Financial News, about 16 hours ago
Outlook on the Migraine Drugs Global Market to 2026 - by Treatment Type, Drug Type, Route of Administration, Distribution Channel and Region - ResearchAndMarkets.com

Outlook on the Migraine Drugs Global Market to 2026 - by Treatment Type, Drug Type, Route of Administration, Distribution Channel and Region - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Migraine Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com''s offering. Th...

Business Wire Business Wire, 2 days ago
Laurence Moon Biedl Syndrome Market Analysis and Forecast 2028 | Novartis AG, Sanofi, Abbott, Pfizer, Inc., AstraZeneca, Bausch Health Companies Inc.

Laurence Moon Biedl Syndrome Market Analysis and Forecast 2028 | Novartis AG, Sanofi, Abbott, Pfizer, Inc., AstraZeneca, Bausch Health Companies Inc.

The recent research report on the Global Laurence Moon Biedl Syndrome Market is aimed to offer data regarding the major work that is happening in the industry over the last few years. It gives a co...

OpenPR OpenPR, 4 days ago